MedTech World and NovaX Sign MoU at Hong Kong Roadshow to Advance Global MedTech Collaboration 

At the opening of today’s MedTech World Hong Kong Roadshow during the NovaX Global Investmatch Carnival 2025, a new chapter in international health innovation was formally launched with the signing of a Memorandum of Understanding (MoU) between MedTech World and NovaX, solidified during the event’s Global Cooperation Signing Ceremony at AsiaWorld-Expo. 

The signing ceremony brought together a group of ecosystem leaders. Dr. Dylan Attard, CEO of MedTech World, and His Excellency John Busuttil, Ambassador of Malta to the People’s Republic of China, were joined by Mr. Raymond Zhao, CEO and Founder of NovaX; Ms. Karena, CEO and Co-Founder of WHub & AngelHub; Mr. Daisuke Tomita, President of the Japan Oral Health Association Medident; Mr. Zhao Lei, Member of the All-China Youth Federation, Chairman of Innovation Hong Kong, and Co-Founder of NovaX; Gao Bo, Member of the All-China Youth Federation, Executive Chairman of the Hong Kong Young Scientists Association, and Cofounder of NovaX; and Mr. Musheer Ahmed, Founder and Managing Director of Finstep Asia.

This agreement signals a shared commitment to strengthening global pathways for investment, startup growth, and international cooperation in the MedTech space. With hundreds of founders, investors, and ecosystem enablers gathered for today’s event, the partnership reinforces both organisations’ ambition to turn collaboration into tangible opportunity. 

“This agreement formalises a relationship that has already been growing in momentum,” said Dr. Dylan Attard, CEO of MedTech World. “Our collaboration with NovaX is built on a joint belief: that health innovation benefits when global ecosystems are connected in practical, deliberate ways. This MoU reflects our intention to not only work together but to build frameworks that last.” 

“By formalising this MoU, we are creating the foundation for more structured, long-term collaboration that will benefit startups, investors, and healthcare stakeholders across Asia, Europe, and beyond. Asia is a key focus for MedTech World moving forward—we’re not only aiming to connect innovators in the region to the global stage, but also to help our ecosystem look more seriously at investing into Asia’s fast-growing healthtech sector,” Dr. Attard noted. 

A Shared Platform for Growth 

Mr. Raymond Zhao, CEO and Founder of NovaX, welcomed the partnership as a natural alignment between two platforms committed to expanding access and scale for MedTech startups worldwide. 

“On behalf of NovaX, we are honored to partner with Medtech World for the NovaX Global Investmatch Carnival 2025. This collaboration highlights our shared commitment to driving innovation and fostering meaningful connections in the MedTech ecosystem. As a leading platform connecting startups with investors, NovaX is excited to join forces with MedTech World, a pioneer in advancing healthcare technology. We aim to leverage our expertise and networks to create transformative opportunities for MedTech innovators and investors. By uniting visionary leaders, groundbreaking startups, and forward-thinking investors in Hong Kong—a gateway to Asia’s dynamic healthcare market—we are poised to redefine how innovation meets investment. Join us in NovaX Carnival and making a lasting impact on the Investmatch world. Together let’s raise fund!” 

Looking Ahead 

With the MoU now in place, MedTech World and NovaX have set the tone for deeper engagement across global markets, particularly in connecting high-growth startups with relevant funding, guidance, and cross-border networks.  

“What’s been formalised here today is a starting point,” said Dr. Attard. “It’s about aligning purpose and practice. We look forward to working closely with NovaX to create new opportunities for innovators building the future of healthcare.” 

For more details about today’s announcement and upcoming programmes including our flagship event, MedTech Malta, contact us at [email protected].